Barriers to satisfactory migraine outcomes. What have we learned, where do we stand?
Barriers to optimal migraine care have traditionally been divided into a number of categories: under-recognition and underconsultation by migraine sufferers; underdiagnosis and undertreatment by health care professionals; lack of follow-up and treatment optimization. These "traditional" barriers have been recognized and addressed for at least 15 years. Epidemiologic studies suggest that consultation, diagnosis, and treatment rates for migraine have improved although many migraine sufferers still do not get optimal treatment. Herein, we revisit the problem, review areas of progress, and expand the discussion of barriers to migraine care. We hypothesize that the subjective nature of pain and difficulty in communicating it contributes to clinical and societal barriers to care. We then revisit some of the traditional barriers to care, contrasting rates of recognition, diagnosis, and treatment over the past 15 years. We follow by addressing new barriers to migraine care that have emerged as a function of the knowledge gained in this process.
Bigal
Marcelo
M
The Merck Research Laboratories, 1 Merck Drive, office WHS-3C26, Whitehouse Station, NJ 08889, USA. marcelo_bigal@merck.com
Krymchantowski
Abouch Valenty
AV
Lipton
Richard B
RB
D003144:Communication Barriers; D006801:Humans; D008881:Migraine Disorders / Q000523:psychology* / Q000628:therapy*; D010817:Physician-Patient Relations; D012017:Referral and Consultation; D011795:Surveys and Questionnaires; D016896:Treatment Outcome